Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover study of fluticasone + salmeterol vs fluticasone in mild to moderate asthma
2005-005305-32Phase 2Completed
- Sponsor
- Neolab Limited
- Start
- Nov 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of salmeterol + fluticasone in asthma (2 arms), sponsored by Neolab Limited. Started Nov 2005; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-005305-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005305-32.